LMAT Stock Recent News
LMAT LATEST HEADLINES
BURLINGTON, Mass., March 01, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four upcoming investor conferences in March.
LeMaitre (LMAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LeMaitre Vascular, Inc. (LMAT) Q4 2023 Earnings Call Transcript
Investors with an interest in Medical - Products stocks have likely encountered both Medtronic (MDT) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better bang for their buck right now?
BURLINGTON, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present virtually at the 26th Annual Needham Growth Conference on Friday, January 19, 2024, at 11:00 AM ET.
Investors interested in Medical - Products stocks are likely familiar with EssilorLuxottica Unsponsored ADR (ESLOY) and LeMaitre Vascular (LMAT). But which of these two stocks is more attractive to value investors?
The consensus price target hints at a 25.2% upside potential for LeMaitre (LMAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer George LeMaitre - Chief Executive Officer David Roberts - President Conference Call Participants Brooks O'Neil - Lake Street Capital Markets LLC Michael Petusky - Barrington Research Associates, Inc. James Sidoti - Sidoti & Company LLC Suraj Kalia - Oppenheimer & Co. Inc. Michael Sarcone - Jefferies Group LLC Scott Henry - ROTH Capital Partners, LLC Operator Welcome to the LeMaitre Vascular Q3 2023 Financial Results Conference Call. After the speaker's presentation, there will be a question-and-answer session.
Investors looking for stocks in the Medical - Products sector might want to consider either PetIQ (PETQ) or LeMaitre Vascular (LMAT). But which of these two stocks is more attractive to value investors?